 ‘FEMALE VIAGRA’ BY RALEIGH FIRM ‘CAN BE USED SAFELY AND EFFECTIVELY IN WOMEN WITH BREAST CANCER’

[{"selector":"#anim-ac22e8f7-3042-48f4-8221-1bd4e948154f","keyframes":{"opacity":[0,1]},"delay":600,"duration":800,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c03462b6-7eea-4776-876d-635a7987ce21","keyframes":{"transform":["translate3d(0px, 128.70370%, 0)","translate3d(0px, 0px, 0)"]},"delay":600,"duration":800,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] ‘Female Viagra’ by Raleigh firm ‘can be used safely and effectively in women with breast cancer’

In interim results, Raleigh-based Sprout Pharmaceuticals' "female Viagra" can "be used safely and effectively in women with breast cancer."

Sprout, which was FDA-approved in 2015, may benefit from the trial.

In 2017, CEO Cindy Eckert and other Sprout stockholders reacquired Sprout from Valeant Pharmaceuticals after the "drug has proven to be worth a tiny fraction of the sales touted upon its approval," according to FiercePharma.

Sprout, which funded $7 million in April, released the Addyi [Flibanserin] trial on Friday.

Addyi is “the first and only FDA-approved non-hormonal pill for acquired, generalized hypoactive (low) sexual desire disorder for premenopausal women,” the business claims.

The 2022 International Society for the Study of Women's Sexual Health Annual Meeting revealed breast cancer study results.

Today's American Society of Clinical Oncology meeting in Chicago will upload the study abstract.

Memorial Sloan Kettering Cancer Center breast medical oncologist Dr. Shari Goldfarb leads the study.

Click here

[{"selector":"#anim-7b5d1b07-c3ff-48da-9c01-6a634112bcea","keyframes":{"opacity":[0,1]},"delay":400,"duration":1600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-97f88a8c-6d28-435f-a3da-8dfbd87d871d","keyframes":{"transform":["translate3d(0px, 236.72844%, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":1600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Check Out More Trending News!